Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/10/26 19:18 | 3/9/26 | HALO | Health | BioPrd | Biological Products, (No Diag | Caudill Cortney | CA | O | SVP,COO | 2 | S.dm | -2,233 | 67.42 | 0 | -33 | 13 | D | |||||||||||||||
3/4/26 18:56 | 10/1/25 | HALO | Health | BioPrd | Biological Products, (No Diag | Torley Helen | CA | DO | P,CEO | 9 | S.dm | -31,786 | 66.70 | 0 | -477 | 768 | D | |||||||||||||||
1/6/26 18:55 | 10/1/25 | HALO | Health | BioPrd | Biological Products, (No Diag | Connaughton Bernadette | CA | D | 5 | S | -782 | 72.22 | 0 | -11 | 47 | D | ||||||||||||||||
9/23/25 16:15 | 9/22/25 | HALO | Health | BioPrd | Biological Products, (No Diag | Labrosse Nicole | CA | O | SVP,CFO | 2 | S.d | -1,688 | 75.94 | 0 | -22 | 24 | D | |||||||||||||||
4/28/25 18:04 | 4/28/25 | HALO | Health | BioPrd | Biological Products, (No Diag | Henderson Jeffrey William | CA | D | 5 | S | -1,379 | 55.15 | 0 | -25 | 44 | D | ||||||||||||||||
2/27/25 18:32 | 2/25/25 | HALO | Health | BioPrd | Biological Products, (No Diag | Labarre Michael J. | CA | O | SVP,CHIE | 1 | S.m | -1,261 | 58.10 | 0 | -22 | 174 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |